We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-4.95%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.9B
AUM Growth
-$320M
Cap. Flow
-$202M
Cap. Flow %
-10.62%
Top 10 Hldgs %
7.71%
Holding
2,190
New
419
Increased
603
Reduced
646
Closed
510

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$17.7M
2
SBUX icon
Starbucks
SBUX
+$16.5M
3
WMB icon
Williams Companies
WMB
+$15.6M
4
HRI icon
Herc Holdings
HRI
+$14.9M
5
DAL icon
Delta Air Lines
DAL
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 14.76%
2 Consumer Discretionary 13.95%
3 Industrials 12.6%
4 Technology 11%
5 Energy 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNT icon
501
Alliant Energy
LNT
$18.3B
$987K 0.05%
35,624
-26,102
-42% -$753K
PATK icon
502
Patrick Industries
PATK
$2.88B
$987K 0.05%
78,624
+47,419
+152% +$603K
CYH icon
503
Community Health Systems
CYH
$417M
$985K 0.05%
21,744
-2,542
-10% -$106K
ZBH icon
504
Zimmer Biomet
ZBH
$18.5B
$985K 0.05%
10,088
-20,800
-67% -$2.05M
CSCD
505
DELISTED
CASCADE MICROTECH, INC.
CSCD
$985K 0.05%
97,263
+13,600
+16% +$155K
SNPS icon
506
Synopsys
SNPS
$77.3B
$984K 0.05%
24,796
-5,245
-17% -$208K
MITT
507
TPG Mortgage Investment Trust
MITT
$227M
$983K 0.05%
18,402
+4,369
+31% +$249K
HBIO icon
508
Harvard Bioscience
HBIO
$28.5M
$982K 0.05%
24,017
+1,498
+7% +$68.9K
MCS icon
509
Marcus Corp
MCS
$959M
$980K 0.05%
62,056
+51,764
+503% +$936K
PKG icon
510
Packaging Corp of America
PKG
$22.8B
$979K 0.05%
15,345
-701
-4% -$47.1K
JBSS icon
511
John B. Sanfilippo & Son
JBSS
$986M
$978K 0.05%
30,227
+14,946
+98% +$434K
CTRX
512
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$976K 0.05%
+23,159
New +$1.05M
WRES
513
DELISTED
WARREN RESOURCES INC
WRES
$976K 0.05%
184,184
+21,400
+13% +$131K
HAL icon
514
Halliburton
HAL
$27B
$973K 0.05%
15,087
-42,585
-74% -$2.92M
EXPR
515
DELISTED
Express, Inc.
EXPR
$973K 0.05%
3,117
+1,403
+82% +$447K
TW
516
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$973K 0.05%
9,779
-642
-6% -$67.7K
KBAL
517
DELISTED
Kimball International
KBAL
$972K 0.05%
82,717
+4,917
+6% +$61.2K
WKC icon
518
World Kinect Corp
WKC
$2B
$971K 0.05%
24,315
+8,930
+58% +$399K
IBKR icon
519
Interactive Brokers
IBKR
$39.5B
$966K 0.05%
154,892
-24,000
-13% -$143K
NNN icon
520
NNN REIT
NNN
$8.97B
$965K 0.05%
27,919
-17,141
-38% -$627K
DPZ icon
521
Domino's
DPZ
$12.2B
$964K 0.05%
12,526
-1,229
-9% -$91.7K
CMP icon
522
Compass Minerals
CMP
$1.25B
$962K 0.05%
11,414
-10,697
-48% -$960K
ASH icon
523
Ashland
ASH
$3.31B
$961K 0.05%
+18,870
New +$983K
HNRG icon
524
Hallador Energy
HNRG
$713M
$960K 0.05%
81,094
+17,180
+27% +$220K
NEM icon
525
Newmont
NEM
$103B
$959K 0.05%
41,597
+26,087
+168% +$665K

Similar funds

GSA Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, GSA Capital Partners held 2,190 positions worth $1.9B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

GSA Capital Partners withdrew a net $202M in Q3 2014, closing 510 positions and reducing 646 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Illumina worth $16.9M.

  • GSA Capital Partners's largest Q3 2014 buy was Illumina: 105,983 shares worth $16.9M.
  • GSA Capital Partners added most to Williams Companies in Q3 2014, an estimated $15.6M increase.
  • GSA Capital Partners's biggest Q3 2014 reduction was Marathon Petroleum, cutting an estimated $24.9M.
  • GSA Capital Partners fully exited Regeneron Pharmaceuticals in Q3 2014, selling an estimated $15.2M.
  • GSA Capital Partners's ten largest holdings make up 7.7% of its $1.9B portfolio in Q3 2014.
  • GSA Capital Partners opened 419 new positions and closed 510 in Q3 2014.
  • GSA Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.9B.

Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.